The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2022

Filed:

Jun. 08, 2017
Applicant:

Alma Mater Studiorum Universita Di Bologna, Bologna, IT;

Inventors:

Valerio Leoni, Faenza, IT;

Maria Gabriella Campadelli, Bologna, IT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61P 35/00 (2006.01); A61K 35/763 (2015.01); A61K 45/06 (2006.01); C07K 14/39 (2006.01); C07K 16/32 (2006.01); C12N 5/09 (2010.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 35/763 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 14/39 (2013.01); C07K 16/32 (2013.01); C12N 5/0693 (2013.01); C12N 7/00 (2013.01); C07K 2317/622 (2013.01); C07K 2319/00 (2013.01); C07K 2319/30 (2013.01); C12N 2710/16622 (2013.01); C12N 2710/16632 (2013.01);
Abstract

The present invention is directed to a recombinant herpesvirus comprising a heterologous peptide and optionally polypeptide ligand capable of binding to (a) target molecule(s) and fused to or inserted into glycoprotein D. The recombinant herpesvirus may additionally comprise modifications for detargeting the virus from the natural receptors of gD. This allows the herpesvirus to efficiently target a cell for therapeutic purposes and a cell for virus production. The present invention further comprises a pharmaceutical composition comprising the herpesvirus, the herpesvirus for use in the treatment of a tumor, infection, degenerative disorder or senescence-associated disease, a nucleic acid and a vector coding for the gD, a polypeptide comprising the gD, and a cell comprising the herpesvirus, nucleic acid, vector or polypeptide. Moreover, a method for infecting a cell with the herpesvirus or for producing the herpesvirus is disclosed.


Find Patent Forward Citations

Loading…